产品展厅_上海阿拉丁生化科技股份有限公司

Indusatumab (anti-GUCY2C),1497400-26-6

Indusatumab (anti-GUCY2C),1497400-26-6
Guselkumab (anti-IL-23),1350289-85-8

Guselkumab (anti-IL-23),1350289-85-8
Vunakizumab (anti-IL-17a),1792181-33-9

Vunakizumab (anti-IL-17a),1792181-33-9
Vantictumab (anti-FZD),1345009-45-1

Vantictumab (anti-FZD),1345009-45-1
Tarextumab (anti-NOTCH3),1359940-55-8

Tarextumab (anti-NOTCH3),1359940-55-8
Seribantumab (anti-ERBB3),1334296-12-6

Seribantumab (anti-ERBB3),1334296-12-6
Ontamalimab (anti-MADCAM1),2098790-40-8

Ontamalimab (anti-MADCAM1),2098790-40-8
Imaprelimab (anti-CD146),2014343-04-3

Imaprelimab (anti-CD146),2014343-04-3
Enokizumab (anti-IL-9),909875-08-7

Enokizumab (anti-IL-9),909875-08-7
Enoblituzumab (anti-CD276),1353485-38-7

Enoblituzumab (anti-CD276),1353485-38-7
Dostarlimab (anti-PD-1),2022215-59-2

Dostarlimab (anti-PD-1),2022215-59-2
Dinutuximab (anti-GD2),1363687-32-4

Dinutuximab (anti-GD2),1363687-32-4
Brazikumab (anti-IL-23),1610353-18-8

Brazikumab (anti-IL-23),1610353-18-8
Bermekimab (anti-IL-1a),1401965-15-8

Bermekimab (anti-IL-1a),1401965-15-8
Avdoralimab (anti-C5AR1),2226393-85-5

Avdoralimab (anti-C5AR1),2226393-85-5
Rilotumumab (anti-HGF),872514-65-3

Rilotumumab (anti-HGF),872514-65-3

第257页